Ventyx Biosciences Inc’s recent filing unveils that its CHIEF BUSINESS OFFICER Krueger Christopher W unloaded Company’s shares for reported $8921.0 on Apr 02 ’24. In the deal valued at $5.40 per share,1,651 shares were sold. As a result of this transaction, Krueger Christopher W now holds 284,999 shares worth roughly $0.7 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Nuss John sold 1,651 shares, generating $8,921 in total proceeds. Upon selling the shares at $5.40, the CHIEF SCIENTIFIC OFFICER now owns 264,998 shares.
Before that, Mohan Raju sold 4,312 shares. Ventyx Biosciences Inc shares valued at $23,299 were divested by the CEO AND PRESIDENT at a price of $5.40 per share. As a result of the transaction, Mohan Raju now holds 1,578,250 shares, worth roughly $3.88 million.
Wells Fargo upgraded its Ventyx Biosciences Inc [VTYX] rating to an Overweight from a an Equal weight in a research note published on March 12, 2024; the price target was increased to $16 from $7. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in mid March from “a Perform” to “an Outperform”. Wells Fargo also remained covering VTYX and has decreased its forecast on November 07, 2023 with a “an Equal weight” recommendation from previously “an Overweight” rating. Stifel revised its rating on November 07, 2023. It rated VTYX as “a Hold” which previously was an “a Buy”.
Price Performance Review of VTYX
On Tuesday, Ventyx Biosciences Inc [NASDAQ:VTYX] saw its stock unchanged to $2.46. Over the last five days, the stock has gained 6.03%. Ventyx Biosciences Inc shares have fallen nearly -0.40% since the year began. Nevertheless, the stocks have fallen -92.88% over the past one year. While a 52-week high of $36.19 was reached on 03/08/24, a 52-week low of $1.79 was recorded on 08/22/24. SMA at 50 days reached $2.28, while 200 days put it at $3.57.
Levels Of Support And Resistance For VTYX Stock
The 24-hour chart illustrates a support level at 2.38, which if violated will result in even more drops to 2.30. On the upside, there is a resistance level at 2.60. A further resistance level may holdings at 2.74. The Relative Strength Index (RSI) on the 14-day chart is 61.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.39%. Stochastics %K at 56.95% indicates the stock is a holding.
How much short interest is there in Ventyx Biosciences Inc?
A steep rise in short interest was recorded in Ventyx Biosciences Inc stocks on 2024-08-30, dropping by -0.45 million shares to a total of 8.56 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 9.01 million shares. There was a decline of -5.22%, which implies that there is a negative sentiment for the stock.
